Peptide Linker Purification on Reusable Solid Phase Supports

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for peptide purification, such as preparative HPLC, are costly, not scalable, and unsuitable for sulfur-containing or copper-binding peptides, and require complex equipment and solvents, while solid phase methods face issues with reuse and stability of solid phases and peptides.

Innovation Solution

A method using linker molecules that immobilize peptide precursors for purification and modification on a solid support, allowing simultaneous purification and modification, suitable for sulfur-containing peptides, and enabling reuse of the solid phase.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If HPLC is used for peptide purification, then purification quality is improved, but production cost increases and scalability decreases

Engineering Contradiction:
Improvepurification qualityVSAvoidscalability
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent introduces a linker molecule as an intermediary that covalently connects the peptide to a solid phase support. This mediator enables the peptide to be immobilized during purification, allowing for simplified purification methods that are more scalable and cost-effective while maintaining purification quality. The linker acts as a bridge between the peptide and the solid phase, facilitating the purification process without requiring complex HPLC systems.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If traditional solid phase methods are used, then purification is achieved, but the solid phase cannot be reused and costs increase

Engineering Contradiction:
Improvepurification effectivenessVSAvoidcost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent implements a system where the solid phase support is recovered and reused after purification. The linker molecule is designed to allow the peptide to be cleaved from the solid phase while the solid phase itself remains intact and can be regenerated for subsequent purification cycles. This recovering aspect eliminates the need to discard the expensive solid phase after single use, significantly reducing production costs while maintaining purification effectiveness.

Inventive Principle:
Principle #34Discarding and recovering

3Manufacturing precision

If sulfur-containing peptides are purified using traditional methods, then purification is attempted, but copper complexation occurs making copper removal difficult and the method inapplicable

Engineering Contradiction:
Improvepurification capabilityVSAvoidcopper toxicity
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent extracts or removes copper from the purification system entirely. By using a solid phase support with specific functional groups that do not require copper for the purification mechanism, the method eliminates copper complexation with sulfur-containing peptides. The linker and solid phase are designed to achieve purification through alternative mechanisms that are compatible with sulfur-containing amino acids, thereby removing the harmful copper toxicity issue while maintaining purification capability.

Inventive Principle:
Principle #2Taking out (Extraction)

4Ease of manufacture

If linear peptides are used, then synthesis is simple, but in vivo stability is low due to fast degradation

Engineering Contradiction:
Improvesynthesis simplicityVSAvoidin vivo stability
Core Design Contradiction:
Ease of manufactureVSStability of the object's composition

Solution Approach 1:

The patent applies preliminary action by performing cyclization of the peptide during the solid phase synthesis process itself, before the peptide is cleaved from the solid phase. The linker molecule facilitates this in-situ cyclization, creating cyclic peptides that have enhanced in vivo stability against proteolytic degradation. This preliminary cyclization step maintains synthesis simplicity while dramatically improving the stability of the final peptide product.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method reduces costs and complexity by eliminating the need for HPLC systems, supports scalable production, and allows for efficient purification and reuse of solid phases, while maintaining peptide stability and functionality.

Implementation Method 1

reversible hydrazone or oxime bonds

Methodology Applied
Scientific EffectHydrazone bond formation: Chemical Bonding

Implementation Method 2

reversible hydrazone or oxime bonds

Methodology Applied
Scientific EffectOxime bond formation: Chemical Bonding

Implementation Method 3

covalently bound to the N-terminal end of the synthesized full-length peptide

Methodology Applied
Scientific EffectCovalent binding: Chemical Bonding

Data Source

PatentUS12624064B2Linker molecule and use thereof in methods for purifying peptides
Publication Date: 2026.05.12 GYROS PROTEIN TECHNOLOGIES AB
  • US12624064B2 patent drawing
  • US12624064B2 patent drawing
  • US12624064B2 patent drawing

AI summary

The present invention relates to a method for the purification of peptides which are produced by solid phase peptide synthesis (SPPS) and corresponding linker molecules for use in said method. Optionally, the peptide may be modified while bound via said linker molecule on a purification support.